Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogenomics of Selective Serotonin Reuptake Inhibitor (SSRI)-Induced Behavioural Activation in Children and Youth (PGx-SImBA)

NCT06763081 is registered in ClinicalTrials.gov with University of Manitoba as lead sponsor.

NCT NCT06763081
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06763081 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogenomics of Selective Serotonin Reuptake Inhibitor (SSRI)-Induced Behavioural Activation in Children and Youth (PGx-SImBA)
Lead sponsor
University of Manitoba
Phase
Observational
Overall status
Recruiting
Start date
March 1, 2025
Completion date
December 31, 2030
Enrollment
160 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

antidepressant drug adverse reaction, anxiety disorders, behavioral activation, major depression, major depressive disorder, obsessive compulsive disorder (ocd)